Abstract:In this work, the nucleobase unit of the antiviral drug remdesivir, 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine, was synthesized through five-step continuous flow. By adapting batch synthetic chemistry, 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine was successfully produced through sequential flow opera-tions from the widely available and inexpensive starting material pyrrole. Under optimal flow conditions, 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine was obtained in 14.1% isolated yield in a total residence time of 79 min with a throughput of 2.96 g center dot h-1. The total residence time was significantly shorter than the total time consumed in batch procedures (> 26.5 h). In flow, the highly exothermic Vilsmeier-Haack and N-amination reactions involving hazardous and unstable intermediates, oxidative liquid-liquid biphasic transformation, and a bromination reaction requiring strict cryogenic conditions are favorably facilitated. The salient feature of this synthesis is that the workup procedures are fully integrated into the reaction sequences by deploying dedicated equipment and separation units, thus forming a stream-lined continuous-flow system that maximizes the overall process efficiency. This method represents a greener and more sustainable process to prepare this nucleobase unit with high efficiency and safety. (c) 2022 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Development of a Large-Scale Cyanation Process Using Continuous Flow Chemistry En Route to the Synthesis of Remdesivir

Weinreb Amide Approach To The Practical Synthesis Of A Key Remdesivir Intermediate

Continuous-Flow Synthesis of the Nucleobase Unit of Remdesivir

Development of a Continuous Flow Process for the Efficient Preparation of Anti-Tuberculosis-Specific Drug TBAJ-876

Synthesis of Remdesivir by Direct Lithiation of Pyrrolo[2,1‐f][1,2,4]triazine Derivatives Enabled C‐Glycosylation

Direct and Catalytic C-Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside

Catalytic Asymmetric Synthesis of the anti-COVID-19 Drug Remdesivir

Scalable electrocatalyzed formation of C–O bonds using flow reactor technology

Development of a multistep reaction cascade for the synthesis of a sacubitril precursor in continuous flow

Development of a Safe and Efficient Continuous Flow Method for the Synthesis of 3‐Difluoromethoxypyridine Derivatives

Improvement of the C -glycosylation Step for the Synthesis of Remdesivir

Development Of A Concise, Scalable Synthesis Of A Ccr1 Antagonist Utilizing A Continuous Flow Curtius Rearrangement

Electrochemical Dearomative Spirocyclization of N ‐acyl Sulfonamides in a Continuous‐flow Cell

Multiphasic Continuous‐Flow Reactors for Handling Gaseous Reagents in Organic Synthesis: Enhancing Efficiency and Safety in Chemical Processes

Chemical Synthesis of the Anti‐COVID‐19 Drug Remdesivir

Establishment and Development of Organolithium-Mediated Continuous Flow Process for Intermediate of Canagliflozin

Photoredox Iridium–Nickel Dual Catalyzed Cross-Electrophile Coupling: from a Batch to a Continuous Stirred-Tank Reactor Via an Automated Segmented Flow Reactor

A platform for automated nanomole-scale reaction screening and micromole-scale synthesis in flow

Continuous Flow Conditions for High Temperature Formation of a Benzodioxan Pharmaceutical Intermediate: Rapid Scaleup for Early Phase Material Delivery

Towards Antibiotic Synthesis in Continuous-Flow Processes